About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Primary Bone Mature B-Cell NHL in Children

NCT07721194·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Centre Hospitalier Universitaire de Nice

Age

0–21

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age \<21 years at diagnosis.
Single or multifocal bone lesions, with or without regional lymph node involvement
Diagnosis of B-cell non-Hodgkin lymphoma had to be histologically confirmed
Enrolled in or treated according to the FAB LMB 96, LMB 2001, or Inter-B-NHL Ritux 2010 studies between 1998 and 2022

You may not be if

Disease extension to organs other than the regional lymph nodes or bones

The record

StatusCompleted

PhaseNo phase

Taking part21

StartedMar 2023

UpdatedJul 22, 2026

Conditions

Lymphoma, Non-Hodgkin

Where1

CHU NICE
Nice, Alpes Maritimes, France

Clareo Health | Primary Bone Mature B-Cell NHL in Children